Literature DB >> 23941884

Ring expansion of vinylaziridines through the strain-release pericyclic reaction: recent developments and applications.

Yu Mi Heo1, Seung-Mann Paek.   

Abstract

Recent syntheses of azetidines, pyrrolidines, piperidines and azepines through cycloaddition or sigmatropic rearrangements of vinylaziridines are described. Applications to natural product synthesis and mechanistic investigations are also summarized.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23941884      PMCID: PMC6269818          DOI: 10.3390/molecules18089650

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Vinylaziridines, which simultaneously possesses electrophilic and nucleophilic centers in their structure, have been regarded as highly valuable synthetic intermediates because of their unique reactivity toward various other reactive species such as activated alkenes, heteroatoms and metallic species [1]. Since the expansion of a vinylaziridine via sigmatropic rearrangement was first ring reported in 1967 [2,3], a variety of these transformations have been shown to offer efficient and valuable synthetic routes to a wide variety of products. Nowadays the vinylaziridine moiety plays an important role in the preparation of 4-, 5-, 6- and 7-membered azacycles according to the selection of reagents and reaction conditions (Scheme 1). Because this transformation releases the severe ring strain of the aziridine ring, this conversion usually proceeds in a highly efficient manner. In light of this unique reactivity and effectiveness, a lot of synthetic research in this area is being carried out even now. In this review recent developments and application of these methodologies in the last decade are summarized.
Scheme 1

Synthetic applications of the vinylaziridine moiety.

Synthetic applications of the vinylaziridine moiety.

2. Results and Discussion

2.1. Azetidines from Vinylaziridines

Synthesis of a β-lactam from a vinylaziridine through insertion of carbon monoxide was published in 1993 (Equation 1 in Scheme 2) [4]. This enabled the preparation of the β-lactam antibiotic PS-5 and initiated studies into related transformations. In the early 2000s, however, a silyl-substituted vinylaziridine was converted into a 6-membered azacycle under similar reaction conditions (Equation 2 in Scheme 2) [5].
Scheme 2

Synthesis of β and δ-lactams from the vinylaziridine.

Synthesis of β and δ-lactams from the vinylaziridine. A recent report from the Aggarwal group at Bristol University suggests a plausible explanation of this discrepancy (Scheme 3) on the basis of a Pd-mediated isomerization and CO insertion mechanism [6]. Once CO is inserted into the carbon, the so-formed π-allyl complex 6 is dominantly and quickly converted to β-lactam 8 (Equation 3 in Scheme 3), but when the substituent is a silyl group, carbonylation occurs at the carbon adjacent to silicon because of the shorter C-Pd bond length [7]. Once Pd(0) is inserted into the carbon adjacent to silicon, it affords cyclization product 11 after protodesilylation (Equation 4 in Scheme 3). Based on this explanation and hypothesis, various reaction conditions were surveyed to control the regioselectivity of this conversion, as shown in Equation 5 in Scheme 3.
Scheme 3

Mechanism of β and δ-lactam formation from vinylaziridines.

Mechanism of β and δ-lactam formation from vinylaziridines.

2.2. Pyrrolidines from Vinylaziridines

Most recent pyrrolidine syntheses from vinylaziridines apply transition metal catalysts, especially Pd(0) species, with an activated π-bond as shown in Scheme 4. In the presence of the metal catalyst the nucleophilic nitrogen and electrophilic C3 cyclize with the activated π-bond in a stereoselective manner.
Scheme 4

Synthesis of 5-membered azacycles from vinylaziridines.

Synthesis of 5-membered azacycles from vinylaziridines. For example, the Alper group reported in 2000 a highly efficient synthetic protocol for preparing 5-membered urea skeletons 16 using Pd(OAc)2, PPh3 and aryl isocyanates (Scheme 5). Instead of isocyanate, carbodiimide or thioisocyanate could also be used to give the corresponding azacycles 18 or 19, respectively in good yield [8]. Because this versatile transformation needed phosphine ligands for the catalytic cycle, it offered the possibility of using chiral ligands to control the enantioselectivity of these reactions.
Scheme 5

Synthesis of 5-membered cyclic ureas from vinylaziridines.

In fact, the Trost group has published a chiral version of this transformation employing the Trost ligand 22 (Scheme 6) [9]. Cycloaddition of benzyl, vinylaziridine 20 and benzyl isocyanate 21 with catalysis by Pd(0) and a chiral phosphine ligand produced the chiral cyclic urea 23 in a highly efficient and enantioselective manner.
Scheme 6

Enantioselective synthesis of cyclic ureas from vinylaziridines.

Synthesis of 5-membered cyclic ureas from vinylaziridines. This reaction could be applied to other aromatic or benzylic aziridines and isocyanates with similar results. This result is a good example of how strain-release cycloaddition can be applied to enantioselective catalysis. Enantioselective synthesis of cyclic ureas from vinylaziridines. Instead of isocyanate, CO2 could be utilized as a π-bond partner. The Aggarwal group reported an application of this transformation with CO2 to form substituted oxazolidinones [10] (Scheme 7). When aryl vinylaziridine 24 was treated with Pd(0), PPh3, CO2 and a quaternary ammonium salt, the desired oxazolidinone 25 was obtained in high yield. This transformation could be performed with various substrates without loss of chirality. Noticeable is the fact that simple CO2, although nonpolar, could be incorporated in this bond formation. The electrophilicity of the CO2 carbon atom is thought to play an important role in the reaction outcome.
Scheme 7

Formation of oxazolidinones from vinylaziridines.

Formation of oxazolidinones from vinylaziridines. An alkene can be used in this transformation as a π-bond partner if it is activated with other substituents. The Yamamoto group demosntrated this type of conversion in 2002 [11]. As shown in Scheme 8, trisubstituted alkene 27 is highly electron deficient because of its two sulfonyl groups. This highly activated π-bond reacted with simple vinylaziridine to produce pyrrolidine 28 in almost quantitative yield, although with low stereoselectivity. This reaction could be applied to other similar substrates in over 69% yield.
Scheme 8

Formation of pyrrolidines from a vinylaziridine and an activated alkene.

Formation of pyrrolidines from a vinylaziridine and an activated alkene. Improvement for this type of reaction was recently achieved by the Aggarwal group [12]. To expand the synthetic applications, methyl vinyl ketone (MVK) was utilized as a Michael acceptor. This replacement of disulfonyl alkene 27 with MVK afforded a general stereoselective route to the pyrrolidine skeleton. This transformation wase utilized successfully in a total synthesis of kainic acid (Scheme 9). This beautiful example shows that the strain-release cycloaddition of vinylaziridines can be applied to synthesize complex natural products.
Scheme 9

Total synthesis of (−)-kainic acid.

Total synthesis of (−)-kainic acid. Like alkenes, electron deficient alkynes also can be utilized in this cycloaddition. Thus the highly electron deficient alkyne 32 was applied to obtain the highly strained [3.2.0] bicyclic diester 34 [13] (Scheme 10). This transformation could be carried out without any metal catalyst because of the intrinsic electrophilicity of alkyne 32, like in the case of CO2. The seven-membered azacycle 33 was suggested as a plausible intermediate.
Scheme 10

Preparation of bicyclic pyrrolines.

Preparation of bicyclic pyrrolines. Instead of Pd (0) species, a copper catalyst was found to be useful in an isomerization of vinylaziridines. Njardarson and coworkers reported that the synthesis of substituted pyrrolidines 37, 39 can be achieved with copper species catalysis and anhydrous hexafluoroacetylacetonate ligand [14]. This reaction is expected to proceed via a 1,3-rearrangement mechanism [15]. This conversion is also applicable to variously substituted vinylaziridines, as shown in Scheme 11 [16].
Scheme 11

Copper catalysis of a [1.3]-rearrangement.

Copper catalysis of a [1.3]-rearrangement. Dual metal catalyzed ring enlargement of vinylaziridines was reported in 2012. The Blum group reported that Au/Pd dual catalysis of substituted vinylaziridine 40 afforded the pyrrolo[1,2a]pyridine 41 in good yield and diastereoselectivity [17] (Scheme 12). Although the complex catalyst and ligand structure hamper its wide application, this result shows that the combination of metal catalysts and ligands can be optimized in this valuable transformation.
Scheme 12

Dual metal catalysis of vinylaziridines.

Dual metal catalysis of vinylaziridines. A Pd-catalyzed ring expansion reaction was also utilized recently in the total synthesis of the natural product (−)-chamobtusin A [18] (Scheme 13). The Aoyagi group reported that a Pd(0)-mediated ring opening of vinylaziridine/C-N bond formation/reductive elimination sequence afforded the tricyclic alkaloid 44 in 92% yield. This synthetic intermediate was then utilized for the total synthesis of (−)-chamobtusin A. This result is another good example of the synthetic efficiency of the strain-release reactions of vinylaziridines.
Scheme 13

Total synthesis of (−)-chamobtusin A.

Total synthesis of (−)-chamobtusin A. Without metal catalysis, thermal rearrangements of vinylaziridines were also reported [19]. Once the vinylaziridines 45 were heated under microwave, the corresponding pyrrolidine derivatives 46 were produced in high yield, as shown in Scheme 14. Employing this procedure, a formal synthesis of (−)-anisomycin, a natural antibiotic, could be performed. Thermal activation of the substituted vinylaziridine 47 afforded the desired PMB substituted pyrrolidine 48 which could be transformed into (−)-anisomycin by known procedures [20].
Scheme 14

Thermal rearrangement of a vinylaziridine and its application to the synthesis of (−)-anisomycin.

Thermal rearrangement of a vinylaziridine and its application to the synthesis of (−)-anisomycin. More spontaneous rearrangements of vinylaziridine were reported in 2011 [21]. During treatment with vinylmagnesium bromide, the desired transformations from the sulfinylketimines 49 to the corresponding vinylaziridines 51 were observed in the crude reaction mixture (Scheme 15). The 1H-HMR analysis showed formation of the desired vinylaziridine derivatives 51 in 33%–61%, 9%–35% of dehalogenated ketimines 50 and 19%–45% of the pyrrolidine derivatives 52 altogether. After purification of the reaction mixture, however, the rearranged pyrrolidine derivatives 52 were isolated as the exclusive major products. This observation means that spontaneous ring expansions of vinylaziridines can also be performed, depending on their substitution pattern.
Scheme 15

Spontaneous rearrangement of vinylaziridines to pyrrolidines.

Spontaneous rearrangement of vinylaziridines to pyrrolidines.

2.3. Piperidines from Vinylaziridines

Since the reports of the Coldman group and Somfai group respectively, the [2,3]-rearrangement of vinylaziridines has been regarded as an efficient methodology to prepare 6-membered azacycles [22,2,3]-wittig rearrangement of vinylaziridines. Tetrahedron. 1995 ">23] (Scheme 16).
Scheme 16

Preparation of pyridine derivatives through [2,3]-sigmatropic rearrangement.

Preparation of pyridine derivatives through [2,3]-sigmatropic rearrangement. Based on the previous result, modification of this conversion was reported in 2004 by the Rowlands group. They had planned that a carbene insertion of diazoacetate into the aziridine would produce an aziridinium ylide 54 to afford the [2,3]-Stevens rearrangement product 55 stereoselectively (Equation 6 in Scheme 17) [2,3]-Stevens rearrangement of aziridinium ions. Tetrahedron Lett.. 2004 ">24]. After extensive survey of reaction conditions, however, this conversion was shown to be hampered by various side reactions or dimerization of metal carbenoid (Equation 7). To avoid this side reaction, instead of intermolecular carbene insertion, intramolecular insertion as shown in Equation 8 was used. When a copper catalyst was added and the reaction mixtures heated in acetonitrile, a [3,5] fused zwitterionic intermediate 58 was formed and converted to desired pyrrolo[1,2a]pyridine derivative 59 in low yield. Although this low chemical yield still represents a drawback of this transformation, the well-designed reaction plan and complex framework of the product are expected to be utilized for more developments and applications.
Scheme 17

Preparation of pyridine derivatives through [2,3]-sigmatropic rearrangement.

2.4. Azepines from Vinylaziridines

Just as a [2,3]-rearrangement of vinylaziridines produces 6-membered azacycles, a [3,3]-rearrangement affords 7-membered azacycles, i.e., azepine skeletons (Scheme 18). It should be noted that this type of ring expansion for vinyl aziridine was historically the first such reaction to be reported [2,3] (Equations 9 and 10 in Scheme 18). So far, many variations or applications of this conversion have been published because it can readily produce generally otherwise unavailable azepine skeletons in a stereoselective manner.
Scheme 18

[3,3]-Sigmatropic rearrangement of vinylaziridines.

Preparation of pyridine derivatives through [2,3]-sigmatropic rearrangement. [3,3]-Sigmatropic rearrangement of vinylaziridines. For example, the Somfai group showed a successful synthesis of the substituted azepine 63 using this rearrangement [25]. Because this transformation is a strain-release reaction, the product 63 is thought to be kinetically favored (Scheme 19).
Scheme 19

Aza-Claisen rearrangement of vinylaziridines.

Aza-Claisen rearrangement of vinylaziridines. More dramatic application of this conversion to natural product synthesis was achieved by the late Prof. Gin in 2007 [26]. For a total synthesis of cephalotaxine and related natural products, this sigmatropic rearrangement of the substituted vinylaziridine 64 was carried out and found to produce the desired benzazepine 65 in moderate yield with just the aid of cesium carbonate in 1,4-dioxane solution (Equation 11 in Scheme 20). Employing this protocol, application to the chirally substituted vinylaziridine 66 was examined. As expected, smooth conversion to the desired benzazepine 67 without loss of chirality was observed. With this efficient skeleton preparation method, a successful synthesis of cephalotaxine and the related natural product (−)-deoxyharringtonine, a potent a nti-leukemia alkaloid, could be completed (Equation 12 in Scheme 20).
Scheme 20

Total synthesis of cephalotaxine and deoxyharringtonine.

Total synthesis of cephalotaxine and deoxyharringtonine. A metal catalyzed version of this type of transformation has also been studied. The Gallo group reported a similar conversion using a ruthenium catalyst as shown in Scheme 21 [27].
Scheme 21

Ruthenium catalyzed aza-Claisen rearrangement.

Ruthenium catalyzed aza-Claisen rearrangement. Thermal activation of aromatic azide 68 produced an aryl-nitrene to afford a vinylaziridine 69 via nitrene insertion into the alkene moiety. This corresponding vinylaziridine was transformed into the desired benzazepine product 70 in good yield. Nickel catalyzed rearrangement of the aziridinylenynes 71 could also be performed with the N-heterocyclic carbene ligand, SIPr [28] (Scheme 22). Ether-tethered vinylaziridine and alkyne cyclize to a mixture of furo[3,4d]azepines 72 and 73 in good conversion. It is interesting that phosphine ligands gave no conversion of the substrate. Although this reaction still needs more development in terms of chemical yield and substrate scope, it has room for application of chiral catalysts and ligands.
Scheme 22

NHC-assisted rearrangement of the vinylaziridine 71.

NHC-assisted rearrangement of the vinylaziridine 71. Independently of the sigmatropic rearrangement, a cycloaddition of isocyanates with vinylaziridines was also executed. When tosyl isocyanate was added to the benzyl vinylaziridine 74, the azepine 75 was obtained in good yield (Scheme 23). It should be noted that choice of solvent can influence the regioselectivity of this conversion [29]. Thus, with DMF as solvent, imidazole derivative 76 was produced as the major isomer, albeit in low chemical yield. When DMF was replaced by CH2Cl2 as solvent, the desired azepine derivatives were produced in good chemical yield and regioselectivity. After an extensive optimization of the reaction conditions, the vinylaziridine 77 could be converted into the urea 78 in 90% yield.
Scheme 23

Cycloaddition of isocyanates to form azepine derivatives.

Cycloaddition of isocyanates to form azepine derivatives.

3. Conclusions

Recent advances in the strain-release ring enlargement of the vinylaziridine moiety were described. Owing to their unique reactivity, vinylaziridines are still regarded as attractive synthetic intermediates, as summarized above. Their further variations, improvements and applications will be a highly active research topic because the reaction still has unmet needs in terms of regio- and stereoselectivity. With this synthetic endeavor, it can be expected that more fruitful results will be realized, just as they were in the last decade.
  17 in total

1.  Application of Chiral Sulfides to Catalytic Asymmetric Aziridination and Cyclopropanation with In Situ Generation of the Diazo Compound We thank Avecia (M.P.), the EPSRC (M.F.), the EU for a Marie Curie Fellowship (E.A.; HPMF-CT-1999-00076), Lu'an Teacher's College and the Education Minister of The Peoples Republic of China (G.F.), and Sheffield University for financial support. We thank Dr. J. Blacker (Avecia), Dr. R. V. H. Jones (Zeneca Agrochemicals), and Dr. R. Fieldhouse (Zeneca Agrochemicals) for their interest and support of this work.

Authors:  Varinder K. Aggarwal; Emma Alonso; Guangyu Fang; Marco Ferrara; George Hynd; Marina Porcelloni
Journal:  Angew Chem Int Ed Engl       Date:  2001-04-17       Impact factor: 15.336

2.  Strain-release rearrangement of N-vinyl-2-arylaziridines. Total synthesis of the anti-leukemia alkaloid (-)-deoxyharringtonine.

Authors:  Joseph D Eckelbarger; Jeremy T Wilmot; David Y Gin
Journal:  J Am Chem Soc       Date:  2006-08-16       Impact factor: 15.419

3.  Aza-[3,3]-Claisen enolate rearrangement in vinylaziridines: stereoselective synthesis of mono-, di-, and trisubstituted seven-membered lactams.

Authors:  U M Lindström; P Somfai
Journal:  Chemistry       Date:  2001-01-05       Impact factor: 5.236

4.  Room temperature ring-opening cyclization reactions of 2-vinylaziridines with isocyanates, carbodiimides, and isothiocyanates catalyzed by

Authors: 
Journal:  J Org Chem       Date:  2000-09-22       Impact factor: 4.354

5.  Rearrangement of N-aryl-2-vinylaziridines to benzoazepines and dihydropyrroles: a synthetic and theoretical study.

Authors:  Simone Fantauzzi; Emma Gallo; Alessandro Caselli; Cristiana Piangiolino; Fabio Ragaini; Nazzareno Re; Sergio Cenini
Journal:  Chemistry       Date:  2009       Impact factor: 5.236

6.  Unprotected vinyl aziridines: facile synthesis and cascade transformations.

Authors:  Sivaraj Baktharaman; Nicholas Afagh; Adelle Vandersteen; Andrei K Yudin
Journal:  Org Lett       Date:  2010-01-15       Impact factor: 6.005

7.  Nickel-catalyzed reactions of vinyl aziridines and aziridinylen-ynes.

Authors:  Gang Zuo; Kainan Zhang; Janis Louie
Journal:  Tetrahedron Lett       Date:  2008-11-24       Impact factor: 2.415

8.  Dynamic kinetic asymmetric cycloadditions of isocyanates to vinylaziridines.

Authors:  Barry M Trost; Daniel R Fandrick
Journal:  J Am Chem Soc       Date:  2003-10-01       Impact factor: 15.419

9.  Lewis acid catalyzed [1,3]-sigmatropic rearrangement of vinyl aziridines.

Authors:  Matthew Brichacek; Dongeun Lee; Jon T Njardarson
Journal:  Org Lett       Date:  2008-10-09       Impact factor: 6.005

10.  Palladium-catalyzed aminoallylation of activated olefins with allylic halides and phthalimide.

Authors:  Kouichi Aoyagi; Hiroyuki Nakamura; Yoshinori Yamamoto
Journal:  J Org Chem       Date:  2002-08-23       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.